Inventor · disambiguated record
Marvin Xuejun Xu
Also filed as: XU MARVIN X · XU MARVIN XUEJUN
6 granted patents·4 pending applications·51 citations·filing 2010–2023
82Inventor score
Files withBAYLOR COLLEGE MEDICINE5HENAN RADIOMEDICAL SCIENCE AND TECH CO LTD2TEXAS A & M UNIV SYS2RUSSELL BROOKE H1
Top patents by PatentIndex Score
10 records- 0193US11161831B2Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexiaBAYLOR COLLEGE MEDICINE·Filed 2020·Granted Nov 2, 2021·6 cites·15 claims
- 0290US10676455B2Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexiaBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Jun 9, 2020·9 cites·14 claims
- 0385US9725498B2Designer collagens and use thereofTEXAS A & M UNIV SYS·Filed 2013·Granted Aug 8, 2017·9 cites·16 claims
- 0484US8618250B2Designer collagens and use thereofRUSSELL BROOKE H·Filed 2010·Granted Dec 31, 2013·13 cites·18 claims
- 0583US10112933B2Methods and compositions for treatment of fibrosisBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Oct 30, 2018·14 cites·23 claims
- 0664US2022227750A1Methods and compositions for prevention of anaphylaxisBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0752US11597756B2Designer collagens and use thereofTEXAS A & M UNIV SYS·Filed 2017·Granted Mar 7, 2023·0 cites·21 claims
- 0852US2023271928A1Naphthylurea compound, methods of preparation and use thereofHENAN RADIOMEDICAL SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 0952US2023331676A1Naphthylurea compound, methods of preparation and use thereofHENAN RADIOMEDICAL SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 1050US2015031714A1Methods and compositions for prevention of allergic reactionBAYLOR COLLEGE MEDICINE·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marvin Xuejun Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →